+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease



Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease



Gut 43(1): 12-16



Background-Atropine reduces the rate of reflux episodes in normal subjects by inhibition of transient lower oesophageal sphincter (LOS) relaxations. The aim of this study was to investigate the effect of atropine on the rate and mechanisms of reflux in patients with reflux disease. Methods-Oesophageal motility and pH were recorded for one hour after a meal in 15 patients with reflux disease. On separate days, atropine (15 mug/kg bolus intravenously, 4 mug/kg/h infusion) or saline were given and maintained for the recording period. Results-Atropine significantly reduced basal LOS pressure from 7.1 (2.2) to 2.9 (1.3) mm Hg (mean (SEM)). Atropine also reduced the rate of reflux episodes from 5.0 (2.0-8.75) to 1.0 (0-6.25) per hour (median (interquartile range)) largely because of a decrease in the rate of transient LOS relaxations from 2.0 (0-4.75) to 0 (0-0) per hour and abolition of reflux during swallow induced LOS relaxation. There was no change in the rate of reflux episodes because of absent basal LOS pressure. Conclusions-Atropine inhibits reflux in patients with reflux disease largely by inhibition of transient LOS relaxations and swallow induced LOS relaxation. These findings suggest that pharmacological control of reflux through control of transient LOS relaxations is possible in patients with reflux disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008524101

Download citation: RISBibTeXText

PMID: 9771399

DOI: 10.1136/gut.43.1.12


Related references

Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut 52(4): 479-485, 2003

Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 50(1): 19-24, 2002

Reproducibility of meal-induced transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease. Neurogastroenterology and Motility 17(1): 23-28, 2005

Loxiglumide inhibits post-prandial transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease. Gastroenterology 112(4 Suppl. ): A315, 1997

Transient lower oesophageal sphincter relaxations--a pharmacological target for gastro-oesophageal reflux disease?. Alimentary Pharmacology and Therapeutics 16(1): 17-26, 2002

Review article: Transient lower oesophageal sphincter relaxations: A pharmacological target for gastro-oesophageal reflux disease?. Alimentary Pharmacology and Therapeutics 16(1): 17-26, 2002

Review article: the clinical relevance of transient lower oesophageal sphincter relaxations in gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 33(6): 650-661, 2011

Treatment of gastro-oesophageal reflux disease through control of transient lower oesophageal sphincter relaxations--feasibility, practicality and possibilities. Digestive and Liver Disease 32(3): 183-187, 2000

Gastro-oesophageal reflux of liquids and gas during transient lower oesophageal sphincter relaxations. Neurogastroenterology and Motility 18(10): 888-893, 2006

The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. Alimentary Pharmacology and Therapeutics 16(9): 1655-1662, 2002

Inhibition of gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in ferrets by GABAB receptor ligands. Gastroenterology 116(4 Part 2): A960, 1999

Transient lower oesophageal sphincter relaxations play an insignificant role in gastro-oesophageal reflux to the proximal oesophagus. Neurogastroenterology and Motility 13(5): 503-509, 2001

Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: A double-blind, placebo-controlled study. Alimentary Pharmacology and Therapeutics 16(4): 743-747, 2002

The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. Alimentary Pharmacology and Therapeutics 14(4): 453-462, 2000

The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease. European Journal of Gastroenterology and Hepatology 14(1): 9-14, 2002